# 3D Systems Corp: Form 10-Q for the period ended Sep 30, 2019

- Company: [3D Systems Corp](/companies/ddd.md) (CIK 910638)
- Form: 10-Q
- Filed: 2019-10-30
- Accepted by EDGAR: Oct 30, 2019, 16:07 ET
- Period: 2019-09-30
- Accession: 0000910638-19-000035
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/910638/000091063819000035/ddd-20190930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/910638/000091063819000035/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-07-01 to 2019-09-30 | $155.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2019-01-01 to 2019-09-30 | $464.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-07-01 to 2019-09-30 | $88.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2019-01-01 to 2019-09-30 | $258.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-07-01 to 2019-09-30 | $67.3m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-01-01 to 2019-09-30 | $206.3m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-07-01 to 2019-09-30 | $20.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2019-01-01 to 2019-09-30 | $63.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2019-07-01 to 2019-09-30 | $58.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2019-01-01 to 2019-09-30 | $195.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-07-01 to 2019-09-30 | −$11.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-01-01 to 2019-09-30 | −$52.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2019-07-01 to 2019-09-30 | $2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-01-01 to 2019-09-30 | $5.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-07-01 to 2019-09-30 | −$16.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-01-01 to 2019-09-30 | −$65.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-07-01 to 2019-09-30 | −$0.15 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months, 2019-01-01 to 2019-09-30 | −$0.57 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months, 2019-01-01 to 2019-09-30 | $10.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-01-01 to 2019-09-30 | $18.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2019-09-30 | $127.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-30 | $391.6m | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-30 | $822.8m | us-gaap:Assets |
| Current liabilities | at 2019-09-30 | $171.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-09-30 | $307.5m | us-gaap:Liabilities |
| Long-term debt | at 2019-09-30 | $55.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-09-30 | $3.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2019-09-30 | $514.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 39,131 characters.

This discussion should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Item 1 (the “Financial Statements”) of this Quarterly Report on Form 10-Q (“Form 10-Q”). We are subject to a number of risks and uncertainties that may affect our future performance that are discussed in greater detail in the sections entitled “Forward-Looking Statements” at the end of this Item 2 and that are discussed or referred to in Item 1A of Part II of this Form 10-Q.

### Business Overview

3D Systems Corporation (“3D Systems” or the “Company” or “we” or “us”) is a holding company incorporated in Delaware in 1993 that markets our products and services through subsidiaries in North America and South America (collectively referred to as “Americas”), Europe and the Middle East (collectively referred to as “EMEA”), and the Asia Pacific region (“APAC”). We provide comprehensive 3D printing solutions, including 3D printers, materials, software, on demand manufacturing services and digital design tools. Our solutions support advanced applications in a wide range of industries and key verticals including healthcare, aerospace, automotive and durable goods. Our precision healthcare capabilities include simulation, Virtual Surgical Planning (“VSP™”), and printing of medical and dental devices, models, surgical guides and instruments. Our solutions, experience and expertise provide an end-to-end digital workflow from design to prototyping to production. As the originator of 3D printing and a shaper of future 3D solutions, for over 30 years we have been enabling professionals and companies to optimize designs, transform workflows, bring innovative products to market and drive new business models.

Customers can use our 3D solutions to design and manufacture complex and unique parts, eliminate expensive tooling, produce parts locally or in small batches and reduce lead times and time to market. A growing number of customers are shifting from prototyping applications to also using 3D printing for production. We believe this shift will be further driven by our continued advancement and innovation of 3D printing solutions that improve durability, repeatability, productivity and total cost of operation.

### Summary of Third Quarter 2019 Financial Results

Total consolidated revenue for the quarter ended September 30, 2019 decreased by 5.6%, or $9.2 million, to $155.3 million, compared to $164.5 million for the quarter ended September 30, 2018. These results reflect a decrease in printers revenue due to the ordering patterns of a large enterprise customer and the exit of our entertainment business, as well as industry decline in manufacturing activity.

Healthcare revenue includes sales of products, materials and services for healthcare-related applications, including simulation, training, planning, anatomical models, surgical guides and instruments and medical and dental devices. For the quarter ended September 30, 2019, healthcare revenue increased by 6.3%, to $56.4 million, and made up 36.3% of total revenue, compared to $53.1 million, or 32.2% of total revenue, for the quarter ended September 30, 2018. The results reflect an increase primarily in materials and services revenues.

For the quarter ended September 30, 2019, total software revenue from products and services increased slightly by 0.1% to $24.6 million, and made up 15.8% of total revenue, compared to $24.6 million, or 14.9% of total revenue, for the quarter ended September 30, 2018.

Gross profit for the quarter ended September 30, 2019 decreased by 13.5%, or $10.5 million, to $67.3 million, compared to $77.8 million for the quarter ended September 30, 2018. Gross profit margin for the quarters ended September 30, 2019 and 2018 was 43.3% and 47.3%, respectively.

Operating expenses for the quarter ended September 30, 2019 decreased by 10.8%, or $9.6 million, to $79.2 million, compared to $88.8 million for the quarter ended September 30, 2018. Selling, general and administrative expenses for the quarter ended September 30, 2019 decreased by 11.2%, or $7.3 million, to $58.3 million, compared to $65.6 million for the quarter ended September 30, 2018. Research and development expenses for the quarter ended September 30, 2019 decreased by 9.7%, or $2.3 million, to $20.9 million, compared to $23.2 million for the quarter ended September 30, 2018.

Our operating loss for the quarter ended September 30, 2019 was $11.9 million, compared to an operating loss of $11.0 million for the quarter ended September 30, 2018.

For the nine months ended September 30, 2019 and 2018, we generated $10.1 million and used $2.9 million of cash from operations, respectively, as further discussed below. In total, our unrestricted cash balance at September 30, 2019 and December 31, 2018, was $127.6 million and $110.0 million, respectively. The higher cash balance was the result of our borrowing on the Senior Credit Facility, offset by repayment of amounts outstanding on the Prior Credit Agreement as well as investments in our facilities and IT infrastructure. For information on the Senior Credit Facility and the Prior Credit Agreement, see Note 7.

### Results of Operations

#### Comparison of revenue

Due to the relatively high price of certain 3D printers and a corresponding lengthy selling cycle and relatively low unit volume of the higher priced printers in any particular period, a shift in the timing and concentration of orders and shipments from one period to another can affect reported revenue in any given period.

In addition to changes in sales volumes, there are two other primary drivers of changes in revenue from one period to another: (1) the combined effect of changes in product mix and average selling prices and (2) the impact of fluctuations in foreign currencies. As used in this Management’s Discussion and Analysis, the price and mix effects relate to changes in revenue that are not able to be specifically related to changes in unit volume.

#### Comparison of revenue by geographic region

The following tables set forth changes in revenue by geographic region for the quarters and nine months ended September 30, 2019 and 2018.

### Table 1

*(Dollars in thousands)*

|  | Americas |  | EMEA |  | Asia Pacific |  | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue — third quarter 2018 | $82,155 | 49.9% | $55,020 | 33.4% | $27,336 | 16.6% | $164,511 | 100.0% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | (8,506) | (10.4)% | 10,919 | 19.8% | (9,875) | (36.1)% | (7,462) | (4.5)% |
| Price/Mix | 4,227 | 5.1% | (3,442) | (6.3)% | (137) | (0.5)% | 648 | 0.4% |
| Foreign currency translation | (50) | (0.1)% | (2,141) | (3.9)% | (234) | (0.9)% | (2,425) | (1.5)% |
| Net change | (4,329) | (5.3)% | 5,336 | 9.7% | (10,246) | (37.5)% | (9,239) | (5.6)% |
| Revenue — third quarter 2019 | $77,826 | 50.1% | $60,356 | 38.9% | $17,090 | 11.0% | $155,272 | 100.0% |

Consolidated revenue decreased by 5.6%, predominantly driven by lower sales volume in the Asia Pacific and Americas regions driven by ordering patterns of a large enterprise customer, on demand solutions and exiting the entertainment business, partially offset by favorable sales volumes in the EMEA region primarily driven by healthcare.

For the quarters ended September 30, 2019 and 2018, revenue from operations outside the U.S. was 51.3% and 50.6% of total revenue, respectively.

### Table 2

*(Dollars in thousands)*

|  | Americas |  | EMEA |  | Asia Pacific |  | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue — nine months 2018 | $254,941 | 50.3% | $169,300 | 33.4% | $82,707 | 16.3% | $506,948 | 100.0% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | (32,949) | (12.9)% | 21,379 | 12.6% | (24,345) | (29.4)% | (35,915) | (7.1)% |
| Price/Mix | 12,837 | 5.0% | (5,448) | (3.2)% | (2,143) | (2.6)% | 5,246 | 1.0% |
| Foreign currency translation | (488) | (0.2)% | (9,455) | (5.6)% | (1,812) | (2.2)% | (11,755) | (2.3)% |
| Net change | (20,600) | (8.1)% | 6,476 | 3.8% | (28,300) | (34.2)% | (42,424) | (8.4)% |
| Revenue — nine months 2019 | $234,341 | 50.5% | $175,776 | 37.8% | $54,407 | 11.7% | $464,524 | 100.0% |

24

Consolidated revenue decreased 8.4%, predominantly driven by lower sales volume in the Americas and Asia Pacific regions which was largely driven by driven by ordering patterns of a large enterprise customer in the prior year and the unfavorable impact of foreign currency, particularly in EMEA, partially offset by increased volume in the EMEA region primarily driven by healthcare and favorable price/mix in the Americas driven by materials and production printers.

For the nine months ended September 30, 2019 and 2018, revenue from operations outside the U.S. was 51.0% and 50.7% of total revenue, respectively.

#### Comparison of revenue by class

We earn revenue from the sale of products, materials and services. The products category includes 3D printers, healthcare simulators and digitizers, software licenses, 3D scanners and haptic devices. The materials category includes a wide range of materials to be used with our 3D printers, the majority of which are proprietary, as well as acquired conventional dental materials. The services category includes maintenance contracts and services on 3D printers and simulators, software maintenance, on demand solutions and healthcare services.

The following tables set forth the change in revenue by class for the quarters and nine months ended September 30, 2019 and 2018.

### Table 3

*(Dollars in thousands)*

|  | Products |  | Materials |  | Services |  | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue — third quarter 2018 | $59,648 | 36.3% | $40,274 | 24.5% | $64,589 | 39.3% | $164,511 | 100.0% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | (6,093) | (10.2)% | 1,337 | 3.3% | (2,706) | (4.2)% | (7,462) | (4.5)% |
| Price/Mix | 264 | 0.4% | 384 | 1.0% | — | —% | 648 | 0.4% |
| Foreign currency translation | (702) | (1.2)% | (606) | (1.5)% | (1,117) | (1.7)% | (2,425) | (1.5)% |
| Net change | (6,531) | (10.9)% | 1,115 | 2.8% | (3,823) | (5.9)% | (9,239) | (5.6)% |
| Revenue — third quarter 2019 | $53,117 | 34.2% | $41,389 | 26.7% | $60,766 | 39.1% | $155,272 | 100.0% |

Consolidated revenue decreased 5.6%, predominantly due to lower products volume which was driven by the impact of ordering patterns of a large enterprise customer, partially offset by revenue from healthcare and metal printers. For the quarters ended September 30, 2019 and 2018, revenue from printers contributed $30.4 million and $36.8 million, respectively. Software revenue included in the products category, including scanners and haptic devices, contributed $13.3 million and $13.6 million for the quarters ended September 30, 2019 and 2018, respectively.

Services revenue decreased due to lower revenue from on demand solutions and from the entertainment business, which the company exited in 2019, and the unfavorable impact of foreign currency translation, partially offset by increased revenue from healthcare. For the quarters ended September 30, 2019 and 2018, revenue from on demand manufacturing services contributed $23.1 million and $26.3 million, respectively. For the quarters ended September 30, 2019 and 2018, software services revenue contributed $11.3 million and $11.0 million, respectively.

### Table 4

*(Dollars in thousands)*

|  | Products |  | Materials |  | Services |  | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue — nine months 2018 | $188,016 | 37.1% | $128,137 | 25.3% | $190,795 | 37.6% | $506,948 | 100.0% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | (30,148) | (16.0)% | (3,614) | (2.8)% | (2,153) | (1.1)% | (35,915) | (19.9)% |
| Price/Mix | 2,674 | 1.4% | 2,572 | 2.0% | — | —% | 5,246 | 3.4% |
| Foreign currency translation | (3,978) | (2.1)% | (3,048) | (2.4)% | (4,729) | (2.5)% | (11,755) | (7.0)% |
| Net change | (31,452) | (16.7)% | (4,090) | (3.2)% | (6,882) | (3.6)% | (42,424) | (8.4)% |
| Revenue — nine months 2019 | $156,564 | 33.7% | $124,047 | 26.7% | $183,913 | 39.6% | $464,524 | 100.0% |

25

Consolidated revenue decreased 8.4%, predominantly driven by the products revenue category which was impacted by ordering patterns of a large enterprise customer and unfavorable impacts of foreign currency translation, only partially offset by revenue from recently launched printer models. For the nine months ended September 30, 2019 and 2018, revenue from printers contributed $90.3 million and $120.2 million, respectively. Software revenue included in the products category, including scanners and haptic devices, contributed $39.2 million and $39.5 million for the nine months ended September 30, 2019 and 2018, respectively.

Materials revenue decreased due to lower sales volume and the unfavorable impact of foreign currency, offset by a favorable impact from price/mix. The decline in volume is driven by weaker demand for materials utilized in older printer models, only partially offset by demand for new materials.

Services revenue decreased primarily due to the unfavorable impact of foreign currency translation. For the nine months ended September 30, 2019 and 2018, revenue from on demand manufacturing services contributed $69.7 million and $79.3 million, respectively. For the nine months ended September 30, 2019 and 2018, software services revenue contributed $33.5 million and $33.0 million, respectively.

#### Gross profit and gross profit margins

The following tables set forth gross profit and gross profit margins for the quarters and nine months ended September 30, 2019 and 2018.

### Table 5

*(Dollars in thousands)*

|  | Quarter Ended September 30, 2019 Gross Profit | Gross Profit Margin | 2018 Gross Profit | Gross Profit Margin | Change in Gross Profit $% |  | Change in Gross Profit Margin Percentage Points% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Products | 8,339 | 15.7% | 17,522 | 29.4% | (9,183) | (52.4)% | (13.7) | (46.6)% |
| Materials | 28,123 | 67.9% | 27,956 | 69.4% | 167 | 0.6% | (1.5) | (2.2)% |
| Services | 30,819 | 50.7% | 32,332 | 50.1% | (1,513) | (4.7)% | 0.6 | 1.2% |
| Total | $67,281 | 43.3% | $77,810 | 47.3% | $(10,529) | (13.5)% | (4.0) | (8.5)% |

The decrease in total consolidated gross profit is due to the decrease in product sales, primarily lower sales of printers.

Products gross profit margin decreased primarily due to under absorption of supply chain overhead resulting from lower production, in addition to the impact of the mix of sales and inventory adjustments. A favorable mix of sales towards higher gross profit margin service offerings and improvements in printer service margins drove services gross profit margin improvements.

### Table 6

*(Dollars in thousands)*

|  | Nine Months Ended September 30, 2019 Gross Profit | Gross Profit Margin | 2018 Gross Profit | Gross Profit Margin | Change in Gross Profit $% |  | Change in Gross Profit Margin Percentage Points% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Products | 28,434 | 18.2% | 57,239 | 30.4% | (28,805) | (50.3)% | (12.2) | (40.1)% |
| Materials | 85,368 | 68.8% | 90,852 | 70.9% | (5,484) | (6.0)% | (2.1) | (3.0)% |
| Services | 92,483 | 50.3% | 93,750 | 49.1% | (1,267) | (1.4)% | 1.2 | 2.4% |
| Total | $206,285 | 44.4% | $241,841 | 47.7% | $(35,556) | (14.7)% | (3.3) | (6.9)% |

The decrease in total consolidated gross profit is due to the decrease in product sales, primarily lower sales of printers.

Products gross profit margin decreased primarily due to under absorption of supply chain overhead resulting from lower production and lower revenue, in addition to the impact of the mix of sales. Materials gross profit margin decreased as a result of the mix of sales. Services gross profit margin improved from a favorable mix of sales towards higher gross profit margin service offerings and improvements in printer service margin.

#### Operating expenses

The following tables set forth the components of operating expenses for the quarters and nine months ended September 30, 2019 and 2018.

### Table 7

*(Dollars in thousands)*

|  | Quarter Ended September 30, 2019 Amount | % Revenue | 2018 Amount | % Revenue | Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative expenses | 58,275 | 37.5% | 65,600 | 39.9% | (7,325) | (11.2)% |
| Research and development expenses | 20,940 | 13.5% | 23,194 | 14.1% | (2,254) | (9.7)% |
| Total operating expenses | $79,215 | 51.0% | $88,794 | 54.0% | $(9,579) | (10.8)% |

Selling, general and administrative expenses decreased primarily due to ongoing reduced personnel and facility expenses related cost optimization efforts, lower amortization from previously acquired intangible assets and decreased legal expenses.

Research and development expenses decreased as we have completed projects related to new products and platforms brought to market in 2018, and prioritized investments in materials and software.

### Table 8

*(Dollars in thousands)*

|  | Nine Months Ended September 30, 2019 Amount | % Revenue | 2018 Amount | % Revenue | Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative expenses | 195,036 | 42.0% | 206,225 | 40.7% | (11,189) | (5.4)% |
| Research and development expenses | 63,654 | 13.7% | 71,788 | 14.2% | (8,134) | (11.3)% |
| Total operating expenses | $258,690 | 55.7% | $278,013 | 54.8% | $(19,323) | (7.0)% |

Selling, general and administrative expenses decreased primarily due to ongoing reduced personnel and facility expenses related cost optimization efforts as well as lower amortization from previously acquired intangible assets.

Research and development expenses decreased as we have completed projects related to new products and platforms brought to market in 2018, and prioritized investments in materials and software.

#### Loss from operations

The following table sets forth (loss) income from operations by geographic region for the quarters and nine months ended September 30, 2019 and 2018.

### Table 9

*(Dollars in thousands)*

| (Loss) income from operations: | Quarter Ended September 30, 2019 | 2018 | Nine Months Ended September 30, 2019 | 2018 |
| --- | ---: | ---: | ---: | ---: |
| Americas | (21,183) | (16,599) | (72,039) | (50,122) |
| EMEA | 7,105 | 386 | 13,499 | (2,948) |
| Asia Pacific | 2,144 | 5,229 | 6,135 | 16,898 |
| Total | $(11,934) | $(10,984) | $(52,405) | $(36,172) |

See “*Comparison of revenue by geographic region,” “Gross profit and gross profit margins”* and “*Operating expenses”* above.

#### Interest and other (expense) income, net

The following table sets forth the components of interest and other (expense) income, net, for the quarters and nine months ended September 30, 2019 and 2018.

### Table 10

*(Dollars in thousands)*

| Interest and other (expense) income, net | Quarter Ended September 30, 2019 | 2018 | Nine Months Ended September 30, 2019 | 2018 |
| --- | ---: | ---: | ---: | ---: |
| Foreign exchange (loss) gain | (1,095) | 1,035 | (2,204) | 2,888 |
| Interest expense, net | (953) | (40) | (2,393) | (35) |
| Other (expense) income, net | (770) | 32 | (2,177) | (1,718) |
| Total interest and other (expense) income, net | $(2,818) | $1,027 | $(6,774) | $1,135 |

The increase in total interest and other expense, net for the quarter ended September 30, 2019 as compared to the quarter ended September 30, 2018 was primarily driven by unfavorable foreign currency impacts, higher interest expense resulting from the Senior Credit Facility and losses recorded on investments.

The increase in total interest and other expense, net for the nine months ended September 30, 2019, as compared to the nine months ended September 30, 2018, was primarily driven by unfavorable foreign currency impacts, higher interest expense resulting from the Senior Credit Facility put in place in the first quarter of 2019 and the impairment of assets sold with the Entertainment business recorded in the second quarter 2019; partially off-set by an adjustment to the fair value of certain cost method investments in the first quarter of 2018.

#### Net loss attributable to 3D Systems

The following tables set forth the primary components of net loss attributable to 3D Systems for the quarters and nine months ended September 30, 2019 and 2018.

### Table 11

*(Dollars in thousands)*

|  | Quarter Ended September 30, 2019 | 2018 | Change |
| --- | ---: | ---: | ---: |
| Loss from operations | $(11,934) | $(10,984) | $(950) |
| Other non-operating items: |  |  |  |
| Interest and other (expense) income, net | (2,818) | 1,027 | (3,845) |
| Provision for income taxes | (2,010) | (1,593) | (417) |
| Net loss | (16,762) | (11,550) | (5,212) |
| Less: net income attributable to noncontrolling interests | 81 | — | 81 |
| Net loss attributable to 3D Systems Corporation | $(16,843) | $(11,550) | $(5,293) |

### Table 12

*(Dollars in thousands)*

|  | Nine Months Ended September 30, 2019 | 2018 | Change |
| --- | ---: | ---: | ---: |
| Loss from operations | $(52,405) | $(36,172) | $(16,233) |
| Other non-operating items: |  |  | — |
| Interest and other (expense) income, net | (6,774) | 1,135 | (7,909) |
| Provision for income taxes | (5,793) | (6,086) | 293 |
| Net loss | (64,972) | (41,123) | (23,849) |
| Less: net income attributable to noncontrolling interests | 195 | 246 | (51) |
| Net loss attributable to 3D Systems Corporation | $(65,167) | $(41,369) | $(23,798) |

The increase in net loss for the quarter and nine months ended September 30, 2019, as compared to the quarter and nine months ended September 30, 2018, was primarily driven by an increase in loss from operations. See “*Gross profit and gross profit margins”* and “*Operating expenses”* above.

### Liquidity and Capital Resources

### Table 13

*(Dollars in thousands)*

|  | September 30, 2019 | December 31, 2018 | Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Cash and cash equivalents | $127,616 | $109,998 | $17,618 | 16.0% |
| Accounts receivable, net | 110,333 | 126,618 | (16,285) | (12.9)% |
| Inventories | 122,706 | 133,161 | (10,455) | (7.9)% |
|  | 360,655 | 369,777 | (9,122) |  |
| Less: |  |  |  |  |
| Current portion of long term debt | 3,025 | — | 3,025 | —% |
| Current right of use liabilities | 10,797 | 654 | 10,143 | 1550.9% |
| Accounts payable | 53,014 | 66,722 | (13,708) | (20.5)% |
| Accrued and other liabilities | 62,701 | 59,265 | 3,436 | 5.8% |
|  | 129,537 | 126,641 | 2,896 |  |
| Operating working capital | $231,118 | $243,136 | $(12,018) | (4.9)% |

We assess our liquidity in terms of our ability to generate cash to fund our operating, investing and financing activities. In doing so, we review and analyze our current cash on hand, the number of days our sales are outstanding, inventory turns, capital expenditure commitments and accounts payable turns. Our cash requirements primarily consist of funding of working capital and funding of capital expenditures.

Cash flow from operations, cash and cash equivalents, and other sources of liquidity such as bank credit facilities and issuing equity or debt securities, are expected to be available and sufficient to meet foreseeable cash requirements. During the first quarter of 2019, we entered into a 5-year $100.0 million senior secured term loan facility (the “Term Facility”) and a 5-year $100.0 million senior secured revolving credit facility (the “Revolving Facility” and, together with the Term Facility, the “Senior Credit Facility”), which replaced the Company's prior $150.0 million 5-year revolving, unsecured credit facility (the "Prior Credit Agreement"), which was terminated in connection with entry into the Senior Credit Facility. Borrowings under the Senior Credit Facility were used to refinance existing indebtedness of $25,000 outstanding under the Prior Credit Agreement and will be used to support working capital and for general corporate purposes. For additional information on the Senior Credit Facility and the Prior Credit Agreement, see Note 7.

As a result of the Term Facility, the Company has exposure to floating interest rates. To manage interest expense, the Company evaluates an appropriate mix of fixed and floating rate debt. In July 2019, the Company entered into a floating to fixed interest rate swap to reduce exposure to changes in floating interest rates on the Term Facility. The interest rate swap has a notional value of $50,000 and will expire on February 26, 2024, concurrent with the Term Facility. The notional value will decline over the term of the interest rate swap as amortization payments reduce the principal amount of the Term Facility. As a result of the interest rate swap, the percentage of total principal debt (excluding capital leases) that is subject to floating interest rates is approximately 15%. The Company designated the swap as a cash flow hedge for accounting treatment.

Cash held outside the U.S. at September 30, 2019 was $85.0 million, or 66.6% of total cash and equivalents, compared to $73.3 million, or 66.7% of total cash and equivalents at December 31, 2018. As our previously unremitted earnings have been subjected to U.S. federal income tax, we expect any repatriation of these earnings to the U.S. would not incur significant additional taxes related to such amounts. However, our estimates are provisional and subject to further analysis. Cash equivalents are comprised of funds held in money market instruments and are reported at their current carrying value, which approximates fair value due to the short term nature of these instruments. We strive to minimize our credit risk by investing primarily in investment grade, liquid instruments and limit exposure to any one issuer depending upon credit quality. See “*Cash flow”* discussion below.

Days’ sales outstanding (DSO) was 65 at September 30, 2019, compared to 69 days for the year at December 31, 2018. Accounts receivable more than 90 days past due increased to 12.0% of gross receivables at September 30, 2019, from 8.9% at December 31, 2018. We review specific receivables periodically to determine the appropriate reserve for accounts receivable.

The majority of our inventory consists of finished goods, including products, materials and service parts. Inventory also consists of raw materials for certain printers and service products. Inventory balances may fluctuate during cycles of new product launch, commercialization and timing of ramp of production and sales of products.

The changes that make up the other components of working capital not discussed above resulted from the ordinary course of business. Differences between the amounts of working capital item changes in the cash flow statement and the balance sheet changes for the corresponding items are primarily the result of foreign currency translation adjustments.

#### Cash flow

The following tables set forth components of cash flow for the nine months ended September 30, 2019 and 2018.

### Table 14

*(Dollars in thousands)*

|  | Nine Months Ended September 30, 2019 | 2018 |
| --- | ---: | ---: |
| Net cash provided by (used in) operating activities | $10,084 | $(2,931) |
| Net cash used in investing activities | (18,389) | (29,550) |
| Net cash provided by (used in) financing activities | 27,333 | (8,906) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (1,400) | (2,417) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $17,628 | $(43,804) |

#### Cash flow from operations

### Table 15

*(Dollars in thousands)*

|  | Nine Months Ended September 30, 2019 | 2018 |
| --- | ---: | ---: |
| Net loss | $(64,972) | $(41,123) |
| Non-cash charges | 61,680 | 66,869 |
| Changes in working capital and all other operating assets | 13,376 | (28,677) |
| Net cash provided by (used in) operating activities | $10,084 | $(2,931) |

Cash provided by operating activities for the nine months ended September 30, 2019 was $10.1 million and cash used in operating activities for the nine months ended September 30, 2018 was $2.9 million. Excluding non-cash charges, the net loss resulted in a use of cash of $3.3 million for the nine months ended September 30, 2019 and provided cash of $25.7 million for the nine months ended September 30, 2018. Non-cash charges generally consist of depreciation, amortization, and stock-based compensation.

Improvements in working capital provided cash of $13.4 million for the nine months ended September 30, 2019 and working capital requirements used cash of $28.7 million for the nine months ended September 30, 2018. In the nine months ended September 30, 2019, drivers of working capital related to cash inflows were a decrease in accounts receivable, inventory and an increase in deferred revenues; partially offset by a decrease in accounts payable and accrued and other current liabilities. In the nine months ended September 30, 2018, cash outflows were driven by increases in inventory, prepaid expenses and a decreases in accrued and other current liabilities; partially offset by an increase in accounts payable and a decrease in accounts receivable.

#### Cash flow from investing activities

### Table 16

*(Dollars in thousands)*

|  | Nine Months Ended September 30, 2019 | 2018 |
| --- | ---: | ---: |
| Purchases of property and equipment | $(18,265) | $(28,323) |
| Proceeds from sale of assets | 1,620 | 9 |
| Other investing activities | (1,744) | (1,236) |
| Net cash used in investing activities | $(18,389) | $(29,550) |

The primary outflow of cash relates to investments in our facilities including our customer innovation centers and healthcare and on-demand facilities as well as continued investments in our IT infrastructure.

#### Cash flow from financing activities

### Table 17

*(Dollars in thousands)*

|  | Nine Months Ended September 30, 2019 | 2018 |
| --- | ---: | ---: |
| Proceeds from borrowings | $100,000 | $— |
| Repayment of borrowings/long term debt | (66,013) | — |
| Payments related to net-share settlement of stock based compensation | (3,029) | (5,723) |
| Purchase of noncontrolling interest | (2,500) | — |
| Payments on earnout consideration | — | (2,675) |
| Other financing activities | (1,125) | (508) |
| Net cash provided by (used in) financing activities | $27,333 | $(8,906) |

Cash provided by financing activities was $27.3 million for the nine months ended September 30, 2019 and cash used in financing activities was $8.9 million for the nine months ended September 30, 2018. The primary inflow of cash for the nine months ended September 30, 2019 relates to borrowing on the Term Facility, partially offset by repayments of the Prior Credit Facility and Term Facility.

### Recent Accounting Pronouncements

Refer to Note 1 - Basis of Presentation of the Notes to Financial Statements (Part I, Item 1 of this Form 10-Q) for further discussion.

### Critical Accounting Policies and Significant Estimates

Our condensed consolidated financial statements are prepared in accordance with GAAP. The preparation of these condensed consolidated financial statements requires us to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses, and related disclosures. On an ongoing basis, we evaluate our estimates and assumptions. Our actual results may differ from these estimates under different assumptions or conditions.

Except for the accounting policies related to lease accounting that were updated as a result of adopting ASC Topic 842, there have been no changes to our critical accounting policies and estimates described in the Annual Report on Form 10-K for the year ended December 31, 2018 (“2018 Form 10-K”), filed with the Securities and Exchange Commission (“SEC”) on February 28, 2019, that have had a material impact on our condensed consolidated financial statements and related notes, other than the following:

Our EMEA, APAC and Americas reporting units carry approximately $182.2 million, $35.5 million and $0 of goodwill, respectively, as of September 30, 2019. Goodwill in the Americas region was written off in 2015. The net carrying values of our long-lived assets in the EMEA, APAC, and Americas regions are approximately $67.5 million, $7.4 million, and $69.3 million, respectively. In our 2018 impairment testing, we determined the EMEA and APAC reporting units had fair values substantially in excess of their carrying values (\>100%). Our 2018 impairment testing also indicated no impairment of long-lived assets in the Americas region as the undiscounted cash flows were substantially in excess of the carrying value of long-lived assets (\>59%). This headroom and recoverability were driven by our forecasts of future operating performance as well as external market indicators.

Our operating performance through September 30, 2019 has been negatively impacted by macroeconomic factors, the decrease and mix of sales, and the ordering patterns of a large enterprise customer. The Company is taking actions to counter these factors, including reducing our cost structure by focusing on cost of sales and operating expenses to drive future profitability. Based on currently available information, the Company continues to believe the fair value of the reporting units exceeds their carrying values and the carrying value of our long-lived assets is recoverable. In the event that these matters are not satisfactorily resolved, the Company could experience a triggering event or impairment of its goodwill or long-lived asset balances in future periods.

### Forward-Looking Statements

Certain statements made in this Form 10-Q that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In many cases, you can identify forward-looking statements by terms such as “believes,” “belief,” “expects,” “estimates,” “intends,” “anticipates,” or “plans” or the negative of these terms or other comparable terminology.

Forward-looking statements are based upon management’s beliefs, assumptions and current expectations concerning future events and trends, using information currently available, and are necessarily subject to uncertainties, many of which are outside our control. Although we believe that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at or by which any such performance or results will be achieved. A number of important factors could cause actual results to differ materially from those indicated by the forward-looking statements. These factors include without limitation:

- competitive industry pressures;
- our ability to deliver products that meet changing technology and customer needs;
- our ability to identify strategic acquisitions, to integrate such acquisitions into our business without disruption and to realize the anticipated benefits of such acquisitions;
- impact of future write-off or write-downs of intangible assets;
- our ability to acquire and enforce intellectual property rights and defend such rights against third party claims;
- our ability to protect our intellectual property rights and confidential information, including our digital content, from third-party infringers or unauthorized copying, use or disclosure;
- failure of our information technology infrastructure or inability to protect against cyber-attack;
- our ability to generate net cash flow from operations;
- our ability to obtain additional financing on acceptable terms;
- our ability to comply with the covenants in our borrowing agreements;
- impact of global economic, political and social conditions and financial markets on our business;
- fluctuations in our gross profit margins, operating income or loss and/or net income or loss;
- our ability to efficiently conduct business outside the U.S.;
- our dependence on our supply chain for components and sub-assemblies used in our 3D printers and other products and for raw materials used in our print materials;
- our ability to manage the costs and effects of litigation, investigations or similar matters involving us or our subsidiaries;
- product quality problems that result in decreased sales and operating margin, product returns, product liability, warranty or other claims;
- our ability to retain our key employees and to attract and retain new qualified employees, while controlling our labor costs;
- our exposure to product liability claims and other claims and legal proceedings;
- disruption in our management information systems for inventory management, distribution, and other key functions;
- compliance with U.S. and other anti-corruption laws, data privacy laws, trade controls, economic sanctions, and similar laws and regulations;
- our ability to comply with the terms of the Administrative Agreement with the U.S. Air Force and to maintain our status as a responsible contractor under federal rules and regulations;
- changes in, or interpretation of, tax rules and regulations; and
- compliance with, and related expenses and challenges concerning, conflict-free minerals regulations; and
- the other factors discussed in the reports we file with or furnishes to the SEC from time to time, including the risks and important factors set forth in additional detail in Item 1A. “Risk Factors” in the 2018 Form 10-K and in Part II, Item 1A. “Risk Factors” in the Quarterly Reports on Form 10-Q for the quarter ended March 31, 2019 (the “2019 Q1 Form 10-Q”) and the quarter ended June 30, 2019 (the “2019 Q2 Form 10-Q” and, together with the 2019 Q1 Form 10-Q and this Form 10-Q, the “2019 Quarterly Reports”).

Certain of these and other factors are discussed in more detail in Item 1A. “Risk Factors” in the 2018 Form 10-K and in the 2019 Quarterly Reports. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements included herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update or review any forward-looking statement made by us or on our behalf, whether as a result of new information, future developments, subsequent events or circumstances or otherwise. All subsequent written or oral forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their entirety by the cautionary statements referenced above.

## Market risk

As filed, 330 characters.

For a discussion of market risks at December 31, 2018, refer to Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” in the 2018 Form10-K. During the first nine months of 2019, there were no material changes or developments that would materially alter the market risk assessment performed as of December 31, 2018.

## Controls and procedures

As filed, 1,465 characters.

#### Evaluation of disclosure controls and procedures

As of September 30, 2019, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) pursuant to Rules 13a-15 and 15d-15 under the Exchange Act. These controls and procedures were designed to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner to allow timely decisions regarding required disclosures. Based on this evaluation, management has concluded that our disclosure controls and procedures were effective as of September 30, 2019.

### Changes in Internal Controls over Financial Reporting

There were no material changes in our internal controls over financial reporting during the period covered by this Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 8,096 characters.

**We disclosed potential violations of U.S. export controls laws to the U.S. federal government that resulted in multiple investigations. We have implemented compliance processes and procedures to identify and prevent potential future violations of export control laws, trade sanctions, and government contracting laws and regulations, and continue to review our government contracting compliance risks and potential violations. Based on the disclosures and investigations, the U.S. Air Force temporarily suspended us from certain new federal contracts and orders in July 2019 and lifted that suspension in September 2019 following the execution of an Administrative Agreement with the Company. Failure to comply with the terms of the Administrative Agreement or the commencement of a separate action by another governmental agency would result in decreased revenues and additional harm to our reputation and otherwise adversely affect our business, operating results and financial condition.**

In October 2017, we received an administrative subpoena from the Bureau of Industry and Security (“BIS”) requesting the production of records in connection with possible violations of U.S. export control laws, including with regard to the On Demand manufacturing business done by our subsidiary, Quickparts.com, Inc. In addition, while collecting information responsive to the above-referenced subpoena, our internal investigation identified potential violations of the International Traffic in Arms Regulations (“ITAR”) administered by the State Department’s Directorate of Defense Trade Controls (“DDTC”) and potential violations of the Export Administration Regulations administered by BIS. On June 8, 2018 and thereafter, we submitted voluntary disclosures to BIS and DDTC identifying numerous potentially unauthorized exports of technical data, which supplemented an initial notice of voluntary disclosure that we submitted to DDTC in February 2018. We have and will continue to implement compliance enhancements to our export controls, trade sanctions, and government contracting compliance to address the issues identified through our internal investigation and cooperate with DDTC and BIS, as well as the U.S. Departments of Justice, Defense, and Homeland Security, in their reviews of these matters.

In addition, on July 19, 2019, we received a notice of immediate suspension of federal contracting from the United States Air Force, pending the outcome of an ongoing investigation. The suspension applied to 3D Systems, its subsidiaries and affiliates, and was related to export controls violations involving 3D Systems’ On Demand manufacturing business described above. Under the suspension, we were generally prohibited from receiving new federal government contracts or subcontracts from any executive branch agency as described in the provisions of 48 C.F.R Subpart 9.4 of the Federal Acquisition Regulation. The suspension allowed us to continue to perform current federal contracts, and also to receive awards of new subcontracts for items under $35,000 and for items considered commercially available off-the-shelf items. The Air Force lifted the suspension on September 6, 2019 following the execution of a two-year Administrative Agreement with the Company. The Company is now eligible to obtain and perform U.S. government contracts and subcontracts without restrictions. Under the Administrative Agreement, the Company will be monitored and evaluated by independent monitors who will report to the Air Force on the Company’s compliance with the terms of the Company’s Ethics & Compliance Program, including its overall culture, government contracting compliance program, and export controls compliance program. The Company’s failure to comply fully with the terms of the Administrative Agreement or the commencement of separate actions by other agencies of the federal government could result in reinstatement of the suspension or debarment from future federal contracting, which would result in decreased revenues and additional harm to our reputation and otherwise adversely affect our business, operating results and financial condition,

Although we cannot predict the ultimate resolution of these matters, we have incurred and expect to continue to incur significant legal costs and other expenses in connection with responding to the U.S. government agencies.

Throughout 2018, we implemented new compliance procedures to identify and prevent potential violations of export controls laws, trade sanctions, and government contracting laws and regulations and created a Compliance Committee of the Board of Directors to further enhance board oversight of compliance risks. As a result of these compliance enhancements, we identified additional potential violations of ITAR, and submitted related voluntary disclosures to DDTC. As we continue to implement additional compliance enhancements throughout 2019, we may discover additional potential violations of export controls laws, trade sanctions, and/or government contracting laws in the future. If we identify any additional potential violations, we will submit voluntary disclosures to the relevant agencies and cooperate with such agencies on any related investigations. Independent monitors will observe and evaluate the Company’s continued compliance with its Ethics & Compliance Program during the term of the Administrative Agreement.

If the U.S. government finds that we have violated one or more export controls laws, trade sanctions, or government contracting laws, we could be subject to various civil or criminal penalties. By statute, these penalties can include but are not limited to fines, which by statute may be significant, denial of export privileges, and suspension or debarment from participation in U.S. government contracts. We may also be subject to contract claims based upon such violations. Any assessment of penalties or other liabilities incurred in connection with these matters could harm our reputation and customer relationships, create negative investor sentiment, and affect our share value. In connection with any resolution, we may also be required to undertake additional remedial compliance measures and program monitoring. We cannot at this time predict when the U.S. government agencies will conclude their investigations or determine an estimated cost, if any, or range of costs, for any penalties, fines or other liabilities to third parties that may be incurred in connection with these matters.

### Our common stock price has been and may continue to be volatile.

The market price of our common stock has experienced, and may continue to experience, considerable volatility. Between January 1, 2018 and October 17, 2019, the trading price of our common stock has ranged from a low of $6.47 per share to a high of $21.78 per share. Numerous factors could have a significant effect on the price of our common stock, including those described or referred to in the “Risk Factors” section of the Form 10-K, the 2019 Q1 Form 10-Q, and the 2019 Q2 Form 10-Q, as well as, among other things:

- Our perceived value in the securities markets;
- Overall trends in the stock market;
- Announcements of changes in our forecasted operating results or the operating results of one or more of our competitors;
- Compliance with the terms of our Administrative Agreement with the U.S. Air Force;
- The impact of changes in our results of operations, our financial condition or our prospects;
- Future sales of our common stock or other securities (including any shares issued in connection with earn-out obligations for any past or future acquisition);
- Market conditions for providers of products and services such as ours;
- Executive level management uncertainty or change;
- Changes in recommendations or revenue or earnings estimates by securities analysts; and
- Announcements of acquisitions by us or one of our competitors.

There have been no other material changes to the risk factors as previously disclosed in the 2018 Form 10-K, the 2019 Q1 Form 10-Q, and the 2019 Q2 Form 10-Q.

Filed Oct 30, 2019.
Source: SEC EDGAR, the filing index for accession 0000910638-19-000035. Last ingested by Listed: Nov 15, 2026, 00:01 ET. No prices; not investment advice.
